Pitha P
Viruses. 2011; 3(7):1179-203.
PMID: 21994776
PMC: 3185785.
DOI: 10.3390/v3071179.
Harty R, Pitha P, Okumura A
J Innate Immun. 2009; 1(5):397-404.
PMID: 19680460
PMC: 2725329.
DOI: 10.1159/000226245.
Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein E
Proc Natl Acad Sci U S A. 2007; 104(5):1655-60.
PMID: 17234809
PMC: 1776164.
DOI: 10.1073/pnas.0610291104.
Okumura A, Lu G, Pitha-Rowe I, Pitha P
Proc Natl Acad Sci U S A. 2006; 103(5):1440-5.
PMID: 16434471
PMC: 1360585.
DOI: 10.1073/pnas.0510518103.
Maillard I, Launois P, Xenarios I, Louis J, Acha-Orbea H, DIGGELMANN H
J Virol. 1998; 72(4):2638-46.
PMID: 9525580
PMC: 109703.
DOI: 10.1128/JVI.72.4.2638-2646.1998.
Effect of interferon on the penetration of murine leukemia virus and the binding of its genome RNA to polyribosomes at the early stage of infection.
Salzberg S, Shurtz R, Feder J, Aboud M
Arch Virol. 1983; 78(3-4):267-78.
PMID: 6661034
DOI: 10.1007/BF01311321.
Reduced synthesis of pp60src and expression of the transformation-related phenotype in interferon-treated Rous sarcoma virus-transformed rat cells.
Lin S, GARBER E, Wang E, CALIGUIRI L, Schellekens H, Goldberg A
Mol Cell Biol. 1983; 3(9):1656-64.
PMID: 6314124
PMC: 370019.
DOI: 10.1128/mcb.3.9.1656-1664.1983.
Increase of cellular murine leukemia virus reverse transcriptase in interferon-treated cells.
Mozes L, Joseph D
Arch Virol. 1984; 79(3-4):285-92.
PMID: 6199004
DOI: 10.1007/BF01310817.
Differential antiviral effects of interferon in three murine cell lines.
Sen G, Herz R
J Virol. 1983; 45(3):1017-27.
PMID: 6187940
PMC: 256509.
DOI: 10.1128/JVI.45.3.1017-1027.1983.
Effect of interferon on the replication of mink cell focus-inducing virus in murine cells: synthesis, processing, assembly, and release of viral proteins.
Bilello J, WIVEL N, Pitha P
J Virol. 1982; 43(1):213-22.
PMID: 6180173
PMC: 256112.
DOI: 10.1128/JVI.43.1.213-222.1982.
Intracellular production of virus particles and viral components in NIH/3T3 cells chronically infected with Moloney murine leukemia virus: effect of interferon.
Aboud M, Kimchi R, Bakhanashvili M, Salzberg S
J Virol. 1981; 40(3):830-8.
PMID: 6172601
PMC: 256694.
DOI: 10.1128/JVI.40.3.830-838.1981.
Cytoplasmic viral DNA synthesis in exogenous infection of murine leukemia virus: effect of interferon and cycloheximide.
Aboud M, Salzberg S
J Virol. 1981; 37(2):836-9.
PMID: 6163875
PMC: 171073.
DOI: 10.1128/JVI.37.2.836-839.1981.
Localization of reverse-transcriptase in interferon-treated mouse cells chronically infected with Moloney leukemia virus.
Sherman L, EYLAN E, Teitz Y
Arch Virol. 1980; 66(2):143-55.
PMID: 6159872
DOI: 10.1007/BF01314982.
Characterization of intracellular viral RNA in interferon-treated cells chronically infected with murine leukemia virus.
Salzberg S, Bakhanashvili M, Bari S, Berman I, Aboud M
J Virol. 1980; 35(3):694-703.
PMID: 6158581
PMC: 288863.
DOI: 10.1128/JVI.35.3.694-703.1980.
Inhibition by interferon of Sendai virus cytolysis.
Sato T, Tomita Y, Kuwata T
Infect Immun. 1980; 28(1):6-10.
PMID: 6155349
PMC: 550885.
DOI: 10.1128/iai.28.1.6-10.1980.
Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
Maheshwari R, Demsey A, MOHANTY S, Friedman R
Proc Natl Acad Sci U S A. 1980; 77(4):2284-7.
PMID: 6154948
PMC: 348698.
DOI: 10.1073/pnas.77.4.2284.
Alterations of a mouse mammary tumor virus glycoprotein with interferon treatment.
Yagi M, King Jr N, BEKESI J
J Virol. 1980; 34(1):225-33.
PMID: 6154805
PMC: 288688.
DOI: 10.1128/JVI.34.1.225-233.1980.
Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon.
Hartshorn K, Sandstrom E, Neumeyer D, Paradis T, Chou T, Schooley R
Antimicrob Agents Chemother. 1986; 30(1):189-91.
PMID: 3019235
PMC: 176465.
DOI: 10.1128/AAC.30.1.189.
Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.
SERGIESCU D, Gerfaux J, Joret A, CHANY C
Proc Natl Acad Sci U S A. 1986; 83(16):5764-8.
PMID: 3016718
PMC: 386375.
DOI: 10.1073/pnas.83.16.5764.
Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha 2-interferon.
Bednarik D, Mosca J, Raj N, Pitha P
Proc Natl Acad Sci U S A. 1989; 86(13):4958-62.
PMID: 2472636
PMC: 297535.
DOI: 10.1073/pnas.86.13.4958.
